Abstract
Pseudotumor cerebri (PTC) is a condition characterized by raised intracranial pressure, normal cerebrospinal fluid contents, and normal brain parenchyma on imaging. In this report, we present a 9-year-old boy with a native kidney disease of familial steroid-resistant nephrotic syndrome due to homozygous NPHS2 mutation, who received a kidney allograft from a living-related donor and developed PTC 3 years after transplant. Ongoing medications included mycophenolate mofetil, cyclosporin, and prednisolone as immunosuppressants. This case describes the resolution of PTC after switching to tacrolimus from cyclosporin. Patients who undergo renal transplantation and are on treatment modalities, including cyclosporine, are at risk of PTC, and prompt evaluation and urgent treatment may prevent blindness.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
